Option Greeks measure how Fulcrum Therapeutics Inc (FULC) option prices respond to changes in the stock price (delta and gamma), the passage of time (theta), implied volatility (vega), and interest rates (rho). These charts plot each Greek by strike, so you can see where an expiration's price risk, time decay, and volatility exposure are concentrated.
Upgrade to view higher order greeks (Vanna, Charm, and Vomma) and multiple expiration dates.
FULC Option Greeks FAQ
What are option Greeks?
Option Greeks measure how an option's price responds to changes in the stock price (delta and gamma), time (theta), implied volatility (vega), and interest rates (rho).
How do I read the FULC Greeks charts?
Gamma, theta, and vega are largest for strikes near the Fulcrum Therapeutics stock price and shrink for strikes far above or below it. Theta grows as expiration gets closer, while vega is larger for expirations further out. Call delta runs from 0 to 1 and put delta from -1 to 0, near 0.50 and -0.50 at the money, and roughly estimates the chance that an option finishes in the money.
How does implied volatility affect FULC's Greeks?
Fulcrum Therapeutics IV rank is 76, so implied volatility is in the upper part of its one-year range. Higher implied volatility raises option premiums and daily time decay (theta), and spreads delta and gamma across a wider range of strikes. Over the past year, 30-day implied volatility ranged from 25.4% to 281.9%. See the FULC implied volatility history for a longer view.
How much gamma and delta do FULC options carry in total?
Across all open Fulcrum Therapeutics options on Nov 17, 2026, net gamma exposure was $28.44K and net delta exposure was $844.82K per 1% move in the stock. The FULC gamma exposure chart shows where that gamma sits by strike.
What is Fulcrum Therapeutics Inc?
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases.